T44-18263-22126
4 vaccinations
8 coded responses
15 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 857 / AZ
- Registered
- 2022-10-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-06
Dose 1 — Moderna
-
2021-03-06
Dose 2 — Moderna
-
2021-11-20
Dose 3 — Moderna
-
2022-10-11
Registered in v-safe
-
2022-10-11
Dose 4 — Moderna
-
2022-10-11
Survey response — day 0, dose 4MedDRA: Dysgeusia — Feeling: Good · Site: Pain · HeadacheFree text: Funny taste in my mouthMedDRA releases: 2024-11 · check-in free text available
-
2022-10-12
Survey response — days 1–6 daily, dose 4MedDRA: Dysgeusia — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesFree text: Better but still slight taste in mouthMedDRA releases: 2024-11 · check-in free text available
-
2022-10-13
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Headache, Fatigue or tiredness, DiarrheaAdult check-in
-
2022-10-14
Survey response — days 1–6 daily, dose 4MedDRA: Injection site induration, Injection site swelling — Feeling: Good · Site: Pain, SwellingFree text: Hard bump at injection siteMedDRA releases: 2024-11 · check-in free text available
-
2022-10-15
Survey response — days 1–6 daily, dose 4MedDRA: Peripheral swelling — Feeling: Good · Site: PainFree text: Bump on arm getting smallerMedDRA releases: 2024-11 · check-in free text available
-
2022-10-16
Survey response — days 1–6 daily, dose 4MedDRA: Injection site swelling — Feeling: Good · Site: PainFree text: Still a small bump under injection siteMedDRA releases: 2024-11 · check-in free text available
-
2022-10-17
Survey response — days 1–6 daily, dose 4MedDRA: Injection site induration, Injection site swelling — Feeling: GoodFree text: Still have a hard bump (not swelling) at injection siteMedDRA releases: 2024-11 · check-in free text available
- 2022-10-18
-
2022-10-27
Survey response — day 14, dose 4MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: FatigueMedDRA releases: 2024-11 · check-in free text available
- 2022-11-01
- 2022-11-08
- 2022-11-15
- 2022-11-22
-
2023-01-10
Survey response — 3 months, dose 4MedDRA: Office visit, Respiratory syncytial virus infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationMedDRA releases: 2024-11
-
2023-01-10
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2023-01-11
- 2023-04-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-06 | Moderna | No |
| 2 | 2021-03-06 | Moderna | No |
| 3 | 2021-11-20 | Moderna | No |
| 4 | 2022-10-11 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 — day 0, dose 4
Systemic reaction (other): Funny taste in my mouth
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Better but still slight taste in mouth
Systemic reaction (other): Hard bump at injection site
Systemic reaction (other): Bump on arm getting smaller
Systemic reaction (other): Still a small bump under injection site
Systemic reaction (other): Still have a hard bump (not swelling) at injection site
Release 12 — day 14, dose 4
Symptoms: Fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SRO | Dysgeusia | · | · | ✓ |
| SRO | Injection site induration | · | · | ✓ |
| SRO | Injection site swelling | · | · | ✓ |
| SRO | Peripheral swelling | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release